Creative Planning Cytosorbents Corp Transaction History

Creative Planning

$90.1 Billion
Q1 2024

A detailed history of Creative Planning transactions in Cytosorbents Corp stock. As of the latest transaction made, Creative Planning holds 21,295 shares of CTSO stock, worth $19,378. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,295

Previous 21,295 -0.0%

Holding current value

$19,378

Previous $23,000 13.04%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$1.39 - $2.46 $2,946 - $5,215	-2,120 Reduced 9.05%	21,295 $29,000
Q2 2022 Aug 15, 2022	BUY	$1.76 - $3.22 $3,731 - $6,826	2,120 Added 9.96%	23,415 $51,000
Q1 2022 May 16, 2022	SELL	$2.88 - $4.23 $2,880 - $4,230	-1,000 Reduced 4.49%	21,295 $68,000
Q4 2021 Feb 11, 2022	BUY	$4.05 - $8.11 $810 - $1,622	200 Added 0.91%	22,295 $93,000
Q3 2021 Nov 10, 2021	BUY	$7.0 - $9.71 $2,100 - $2,913	300 Added 1.38%	22,095 $179,000

Q2 2021 Aug 04, 2021	SELL	$7.55 - $9.42 $36,240 - $45,216	-4,800 Reduced 18.05%	21,795 $165,000
Q4 2020 Jan 29, 2021	BUY	$7.65 - $8.98 $1,530 - $1,796	200 Added 0.76%	26,595 $212,000
Q3 2020 Nov 05, 2020	SELL	$7.37 - $11.54 $61,465 - $96,243	-8,340 Reduced 24.01%	26,395 $211,000
Q2 2020 Jul 23, 2020	BUY	$6.28 - $10.59 $17,414 - $29,366	2,773 Added 8.68%	34,735 $344,000
Q1 2020 May 05, 2020	SELL	$3.77 - $7.73 $8,588 - $17,608	-2,278 Reduced 6.65%	31,962 $247,000
Q4 2019 Jan 30, 2020	SELL	$3.61 - $5.22 $541 - $783	-150 Reduced 0.44%	34,240 $132,000
Q1 2019 Apr 24, 2019	BUY	$6.82 - $8.56 $2,046 - $2,568	300 Added 0.88%	34,390 $260,000
Q3 2018 Oct 25, 2018	SELL	$10.95 - $14.8 $219,000 - $296,000	-20,000 Reduced 36.98%	34,090 $440,000
Q2 2018 Jul 20, 2018	BUY	$6.9 - $12.35 $373,221 - $668,011	54,090 New	54,090 $617,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Cytosorbents Corp Transaction History